Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Drew Griffin Levy"'
Publikováno v:
Clinical Drug Investigation. 29:791-802
Baseline blood pressure (BP) is a strong predictor of response to antihypertensive therapy and the patient's ability to reach BP goals. The objective of this study was to evaluate the role of baseline BP as a determinant of systolic BP (SBP) and trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae3444585e4339cd1e24fcf1f88678e0
https://doi.org/10.2165/11530600-000000000-00000
https://doi.org/10.2165/11530600-000000000-00000
Publikováno v:
Journal of the American Society of Hypertension. 2:476-483
We evaluated the relationship between age and treatment response from pooled data from two randomized trials in which 1,464 patients with Stage 2 hypertension were treated with valsartan alone or in combination with hydrochlorothiazide (HCTZ). Multiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cb2242613b6819a3478a2b4d81610b4
https://doi.org/10.1016/j.jash.2008.06.003
https://doi.org/10.1016/j.jash.2008.06.003
Publikováno v:
J Clin Hypertens (Greenwich)
Subgroup analyses were performed for the diabetic and nondiabetic cohorts from 3 randomized clinical trials that had evaluated the systolic blood pressure (SBP)-lowering efficacy and tolerability of an angiotensin receptor blocker, valsartan, alone o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62b969fa6e62d0650aebb305755d42d0
https://doi.org/10.1111/j.1751-7176.2008.00003.x
https://doi.org/10.1111/j.1751-7176.2008.00003.x
Autor:
Venkatram Kuturu, Ricardo Rocha, Matthew R. Weir, Nora Crikelair, Drew Griffin Levy, Robert Glazer
Publikováno v:
J Clin Hypertens (Greenwich)
This patient data meta‐analysis included 9 randomized, double‐blind, placebo‐controlled trials (N=4278) of once‐daily valsartan 80, 160, or 320 mg or valsartan/hydrochlorothiazide 80/12.5, 160/12.5, 160/25, 320/12.5, or 320/25 mg given for 4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f73aebf27faf45a783299ff9655265d
https://doi.org/10.1111/j.1524-6175.2007.06415.x
https://doi.org/10.1111/j.1524-6175.2007.06415.x
Publikováno v:
Blood pressure. Supplement. 2
To describe the real-world effectiveness of amlodipine add-on therapy for hypertensive patients receiving valsartan.Retrospective cohort study based on USA electronic medical records. The study population included hypertensive patients who, between J
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9450d5180736210a088db872a0da531c
https://pubmed.ncbi.nlm.nih.gov/19205091
https://pubmed.ncbi.nlm.nih.gov/19205091
Publikováno v:
The Annals of pharmacotherapy. 42(2)
Background: Although information concerning the attainment of goal blood pressure for patients commencing antihypertensive therapy is available from controlled trials, no studies have examined this issue in the context of typical clinical practice. O
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f162346bdd76339e12056fd2cf9626f3
https://pubmed.ncbi.nlm.nih.gov/18182472
https://pubmed.ncbi.nlm.nih.gov/18182472
Autor:
Ricardo Rocha, Nora Crikelair, Drew Griffin Levy, Robert Glazer, Matthew R. Weir, Xiangyi Meng
Publikováno v:
American journal of hypertension. 20(7)
Our objective was to assess time to achieve blood-pressure (BP) goal with incremental doses of valsartan alone, and together with hydrochlorothiazide (HCTZ), in patients with uncomplicated hypertension.This analysis pooled patient-level data from nin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4353ade435cbdc9c53cccc5bc3b53adf
https://pubmed.ncbi.nlm.nih.gov/17586417
https://pubmed.ncbi.nlm.nih.gov/17586417